Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.
| Title | Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications. |
| Publication Type | Journal Article |
| Year of Publication | 2017 |
| Authors | Polyzos, S. A., & Mantzoros C. S. |
| Journal | Metabolism |
| Volume | 72 |
| Pagination | A4-A10 |
| Date Published | 2017 07 |
| ISSN | 1532-8600 |
| Keywords | Cost-Benefit Analysis, Humans, Leptin, Lipodystrophy, Randomized Controlled Trials as Topic, Registries |
| DOI | 10.1016/j.metabol.2017.06.003 |
| Alternate Journal | Metab. Clin. Exp. |
| PubMed ID | 28641789 |
